Impel NeuroPharma Inc. Stock, NASDAQ:IMPL
201 Elliott Avenue West, Suite 260, Seattle, Washington 98119
United States of America
Number of Employees: 63
Impel NeuroPharma, Inc. operates as clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders. The firm product candidates includes TRUDHESA, INP105, and INP107. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.